A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Clinical trial NCT06379789 · RECRUITING
Trial details
- NCT number
- NCT06379789
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-11
- Primary completion
- 2034-08-14
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.